Literature DB >> 19891803

A controlled family study of children with DSM-IV bipolar-I disorder and psychiatric co-morbidity.

J Wozniak1, S V Faraone, E Mick, M Monuteaux, A Coville, J Biederman.   

Abstract

BACKGROUND: To estimate the spectrum of familial risk for psychopathology in first-degree relatives of children with unabridged DSM-IV bipolar-I disorder (BP-I).
METHOD: We conducted a blinded, controlled family study using structured diagnostic interviews of 157 children with BP-I probands (n=487 first-degree relatives), 162 attention deficit hyperactivity disorder (ADHD) (without BP-I) probands (n=511 first-degree relatives), and 136 healthy control (without ADHD or BP-I) probands (n=411 first-degree relatives).
RESULTS: The morbid risk (MR) of BP-I disorder in relatives of BP-I probands (MR=0.18) was increased 4-fold [95% confidence interval (CI) 2.3-6.9, p<0.001] over the risk to relatives of control probands (MR=0.05) and 3.5-fold (95% CI 2.1-5.8, p<0.001) over the risk to relatives of ADHD probands (MR=0.06). In addition, relatives of children with BP-I disorder had high rates of psychosis, major depression, multiple anxiety disorders, substance use disorders, ADHD and antisocial disorders compared with relatives of control probands. Only the effect for antisocial disorders lost significance after accounted for by the corresponding diagnosis in the proband. Familial rates of ADHD did not differ between ADHD and BP-I probands.
CONCLUSIONS: Our results document an increased familial risk for BP-I disorder in relatives of pediatric probands with DSM-IV BP-I. Relatives of probands with BP-I were also at increased risk for other psychiatric disorders frequently associated with pediatric BP-I. These results support the validity of the diagnosis of BP-I in children as defined by DSM-IV. More work is needed to better understand the nature of the association between these disorders in probands and relatives.

Entities:  

Mesh:

Year:  2009        PMID: 19891803      PMCID: PMC3077106          DOI: 10.1017/S0033291709991437

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  44 in total

1.  Parsing the association between bipolar, conduct, and substance use disorders: a familial risk analysis.

Authors:  J Biederman; S V Faraone; J Wozniak; M C Monuteaux
Journal:  Biol Psychiatry       Date:  2000-12-01       Impact factor: 13.382

2.  Heterogeneity of childhood conduct disorder: further evidence of a subtype of conduct disorder linked to bipolar disorder.

Authors:  J Wozniak; J Biederman; S V Faraone; H Blier; M C Monuteaux
Journal:  J Affect Disord       Date:  2001-05       Impact factor: 4.839

3.  Diagnostic characteristics of 93 cases of a prepubertal and early adolescent bipolar disorder phenotype by gender, puberty and comorbid attention deficit hyperactivity disorder.

Authors:  B Geller; B Zimerman; M Williams; K Bolhofner; J L Craney; M P Delbello; C A Soutullo
Journal:  J Child Adolesc Psychopharmacol       Date:  2000       Impact factor: 2.576

4.  Attention deficit hyperactivity disorder with bipolar disorder in girls: further evidence for a familial subtype?

Authors:  S V Faraone; J Biederman; M C Monuteaux
Journal:  J Affect Disord       Date:  2001-04       Impact factor: 4.839

5.  Depression in attention deficit hyperactivity disorder (ADHD) children: "true" depression or demoralization?

Authors:  J Biederman; E Mick; S V Faraone
Journal:  J Affect Disord       Date:  1998-01       Impact factor: 4.839

6.  Psychosocial functioning in a prepubertal and early adolescent bipolar disorder phenotype.

Authors:  B Geller; K Bolhofner; J L Craney; M Williams; M P DelBello; K Gundersen
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2000-12       Impact factor: 8.829

7.  Patterns of alcohol and drug use in adolescents can be predicted by parental substance use disorders.

Authors:  J Biederman; S V Faraone; M C Monuteaux; J A Feighner
Journal:  Pediatrics       Date:  2000-10       Impact factor: 7.124

8.  Attention-deficit hyperactivity disorder with bipolar disorder: a familial subtype?

Authors:  S V Faraone; J Biederman; D Mennin; J Wozniak; T Spencer
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1997-10       Impact factor: 8.829

9.  New insights into the comorbidity between ADHD and major depression in adolescent and young adult females.

Authors:  Joseph Biederman; Sarah W Ball; Michael C Monuteaux; Eric Mick; Thomas J Spencer; Michelle McCREARY; Michelle Cote; Stephen V Faraone
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2008-04       Impact factor: 8.829

10.  Child bipolar I disorder: prospective continuity with adult bipolar I disorder; characteristics of second and third episodes; predictors of 8-year outcome.

Authors:  Barbara Geller; Rebecca Tillman; Kristine Bolhofner; Betsy Zimerman
Journal:  Arch Gen Psychiatry       Date:  2008-10
View more
  17 in total

1.  Independence of familial transmission of mania and depression: results of the NIMH family study of affective spectrum disorders.

Authors:  K R Merikangas; L Cui; L Heaton; E Nakamura; C Roca; J Ding; H Qin; W Guo; Y Y Shugart; Y Yao-Shugart; C Zarate; J Angst
Journal:  Mol Psychiatry       Date:  2013-10-15       Impact factor: 15.992

2.  Tools to improve differential diagnosis of bipolar disorder in primary care.

Authors:  J Sloan Manning
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2010

3.  Further evidence that pediatric-onset bipolar disorder comorbid with ADHD represents a distinct subtype: results from a large controlled family study.

Authors:  Joseph Biederman; Stephen V Faraone; Carter Petty; Marykate Martelon; K Yvonne Woodworth; Janet Wozniak
Journal:  J Psychiatr Res       Date:  2012-09-11       Impact factor: 4.791

4.  Family-based association study of early growth response gene 3 with child bipolar I disorder.

Authors:  Amelia L Gallitano; Rebecca Tillman; Valentin Dinu; Barbara Geller
Journal:  J Affect Disord       Date:  2012-02-25       Impact factor: 4.839

5.  Severe mood dysregulation, irritability, and the diagnostic boundaries of bipolar disorder in youths.

Authors:  Ellen Leibenluft
Journal:  Am J Psychiatry       Date:  2010-12-01       Impact factor: 18.112

6.  Further evidence for robust familiality of pediatric bipolar I disorder: results from a very large controlled family study of pediatric bipolar I disorder and a meta-analysis.

Authors:  Janet Wozniak; Stephen V Faraone; Marykate Martelon; Hannah N McKillop; Joseph Biederman
Journal:  J Clin Psychiatry       Date:  2012-10       Impact factor: 4.384

7.  Personal and familial correlates of bipolar (BP)-I disorder in children with a diagnosis of BP-I disorder with a positive child behavior checklist (CBCL)-severe dysregulation profile: a controlled study.

Authors:  Joseph Biederman; Marykate Martelon; Stephen V Faraone; K Yvonne Woodworth; Thomas J Spencer; Janet R Wozniak
Journal:  J Affect Disord       Date:  2012-11-17       Impact factor: 4.839

8.  Can pediatric bipolar-I disorder be diagnosed in the context of posttraumatic stress disorder? A familial risk analysis.

Authors:  Joseph Biederman; Janet Wozniak; Mary Kate Martelon; Thomas J Spencer; Yvonne Woodworth; Gagan Joshi; Andrea Spencer; Mai Uchida; Amelia Kotte; Stephen V Faraone
Journal:  Psychiatry Res       Date:  2013-06-20       Impact factor: 3.222

9.  Toward defining deficient emotional self-regulation in children with attention-deficit/hyperactivity disorder using the Child Behavior Checklist: a controlled study.

Authors:  Thomas J Spencer; Stephen V Faraone; Craig B H Surman; Carter Petty; Allison Clarke; Holly Batchelder; Janet Wozniak; Joseph Biederman
Journal:  Postgrad Med       Date:  2011-09       Impact factor: 3.840

10.  Does sex moderate the clinical correlates of pediatric bipolar-I disorder? Results from a large controlled family-genetic study.

Authors:  Janet Wozniak; Joseph Biederman; Mary Kate Martelon; Mariely Hernandez; K Yvonne Woodworth; Stephen V Faraone
Journal:  J Affect Disord       Date:  2013-02-26       Impact factor: 4.839

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.